Invyncible review

Invyncible publishes a full menu with a figure against every product: sermorelin at $179.10, NAD⁺ injections or nasal spray at $192, glutathione at $88, each shown against a higher struck-through price. It also publishes the caveat — its own FAQ says several programs last about four to five weeks, so these are displayed program prices, not established calendar-month rates; the duration of a specific vial depends on prescription and pharmacy. It lists the six compounding pharmacies in its network by name, address and phone. What it lacks is a named medical director or a dedicated refund policy among the linked pages reviewed.

Invyncible is a telehealth brand operating as Nationwide Telemedicine, LLC from 204 37th Ave N., #337, St. Petersburg, Florida, with a published phone number and a LegitScript verification seal in the footer. Its treatments page lists a full catalog with prices: compounded semaglutide and tirzepatide in several formulations including an oral semaglutide capsule, brand-name Zepbound and Wegovy, Sermorelin 9 mg at $179.10, NAD⁺ injections and an NAD⁺ nasal spray at $192 each, glutathione injections at $88 and a dissolvable glutathione at $130.50, plus MIC+B12, B12 and low-dose naltrexone. Most prices are displayed as a reduction from a higher struck-through figure. It is explicit about its role: "We are not a pharmacy. If prescribed, medication is fulfilled by a pharmacy." Its team page names a founder, an operations lead and a patient-support lead; no clinician is named.

Online intake, physician review, and fulfillment by a pharmacy in its network — with the role boundary stated by the company itself. Its FAQ says a physician reviews each intake before a prescription decision, that a consultation may be required depending on the treatment and state rules, and that a prescription is not guaranteed. Payment is taken as an authorization at checkout and is finalized only if the physician approves; if not, the hold is released, which is a better sequence than a flat pay-first flow. It also states that you may choose the pharmacy your prescription goes to, or request a copy of it. State coverage is published on its About page as 46 states plus Washington, D.C., with California, Mississippi, New Mexico and Oregon excluded; the sermorelin and NAD⁺ product pages carry a shorter notice naming California and Oregon, so confirm your state at intake. The FAQ allows five to seven business days for review and pharmacy processing before shipping. There is no long-term commitment, and refills are not automatic. What is missing is clinical leadership: no medical director is named, and the affiliated medical practices are described only as independently owned.

A fully published menu, and one that needs its own footnote. Sermorelin 9 mg is listed at $179.10 against a struck-through $199, NAD⁺ injections and the NAD⁺ nasal spray at $192 against $240, and glutathione injections at $88 against $110, all visible on product pages before intake. The reduced figures are displayed on product pages; the site does not establish the selected checkout amount, sale end date or future refill rate. These are displayed product or program prices, not established monthly rates: the FAQ says "several programs last about 4-5 weeks", and the sermorelin page notes that vial size and concentration vary by prescription and pharmacy. So comparing $179.10 against a competitor's $199 a month is not like for like until you know how long the 9 mg sermorelin vial lasts at your dose. The FAQ also says the price can rise when a dose increases. The shipping page describes overnight transit after dispatch but does not establish the charge. No dedicated refund policy was found among the linked pages reviewed; ask about both before ordering.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Invyncible publishes its compounding pharmacy network by name — Empower Pharmacy, Strive Pharmacy, Center City Pharmacy, Partell Pharmacy, PerfectRx and MFV Compounding Pharmacy, each with an address and phone number — though it does not say which one fills a given product in a given state. That list turns an unnamed compounder into something you can look up, and it is worth doing, because compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. The sermorelin page is also unusually candid about evidence: it states that compounded sermorelin "has not been established as an anti-aging treatment" or proven to improve sleep, energy, recovery or body composition. That matches the evidence. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism, but the long-term human outcome data stays thin. Injected and intranasal NAD⁺ have no controlled human outcome trials; the oral precursors NR and NMN are the studied forms and raise blood NAD⁺, a biomarker rather than a benefit. Injectable glutathione has essentially no controlled human outcome evidence at all. Individual results vary.